IPP Bureau
Combination of Covishield-Covaxin more effective: AIG hospital study
By IPP Bureau - January 04, 2022
The first pilot study from India analyzing Covaxin-Covishield mixed doses
Domestic and emerging markets will drive pharma growth: ICRA
By IPP Bureau - January 04, 2022
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Dr Reddy’s molnupiravir priced at Rs 1,400 for a course
By IPP Bureau - January 04, 2022
Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.
Yokogawa invests in glycan production company GlyTech
By IPP Bureau - January 04, 2022
Partnering to build biosynthesis processes and a pharmaceutical production platform
Emcure to launch oral Covid-19 drug soon
By IPP Bureau - January 03, 2022
A toll-free helpline to be set up to help doctors and patients
Novavax submits data to U.S. FDA for Covid-19 EUA
By IPP Bureau - January 03, 2022
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Ascletis expands ritonavir oral tablet production
By IPP Bureau - January 03, 2022
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
Snapdeal to promote Ayushman Bharat Digital Mission’s Heath ID
By IPP Bureau - January 03, 2022
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
U.S. FDA grants EUA for Pfizer-BioNTech booster for 12 years and older
By IPP Bureau - January 03, 2022
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region
By IPP Bureau - December 30, 2021
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
Comar expands packaging solutions with Omega acquisition
By IPP Bureau - December 30, 2021
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Quidel’s Antigen tests can detect Omicron variant
By IPP Bureau - December 30, 2021
The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants
Biological E gets nod to study Corbevax as a booster dose
By IPP Bureau - December 30, 2021
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
By IPP Bureau - December 30, 2021
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Green ChemisTree Foundation announces virtual conference on Innovations in Green & Sustainable Chemistry for Pharma Industry
By IPP Bureau - December 30, 2021
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
